Kelyniam Global(OTC) KLYG

Market Cap$6.52M

Since IPO (2008)-53%

5 Year-45%

1 Year+73%

1 Month-1%

$0.13

+5.61%

+0.01Today

Kelyniam Global last closing stock price
Metric	Price	Date
Last close	USD 0.13	2026-09-08

Kelyniam Global stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+5.61%	USD 0.12	2026-08-31
1 month	-0.92%	USD 0.13	2026-08-06
3 month	-7.14%	USD 0.14	2026-06-08
Year to date	+11.59%	USD 0.12	2025-12-31
1 year	+73.33%	USD 0.08	2025-09-08
3 year	+58.73%	USD 0.08	2023-09-06
5 year	-45.49%	USD 0.24	2021-09-09
Since inception	-52.73%	USD 0.28	2008-04-03

Kelyniam Global Financials at a Glance

Market Cap

$6.52M

Revenue (TTM)

$3.59M

Net Income (TTM)

-$215.44K

EPS (TTM)

-$0.00

P/E Ratio

-30.95

Dividend

$0.00

Beta (Volatility)

0.31 (Low)

Dividend

$0.00

Beta (Volatility)

0.31 (Low)

Price

$0.13

Volume

1,100

Open

$0.13

Price

$0.13

Volume

1,100

Open

$0.13

Previous Close

$0.13

Daily Range

$0.13 - $0.13

52-Week Range

$0.07 - $0.30

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.31 (Low)

Price

$0.13

Volume

1,100

Open

$0.13

Previous Close

$0.13

Daily Range

$0.13 - $0.13

52-Week Range

$0.07 - $0.30

Estimated Earnings Date

N/A

KLYG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kelyniam Global

Kelyniam Global, Inc. is a medical device manufacturer specializing in custom prosthetics and cranial fixation solutions. Established in 2005, the company utilizes advanced computer-aided design and manufacturing processes to create high-quality medical devices for patients and healthcare providers.

Products and Services

Custom prosthetics using advanced medical-grade polymers
Cranial and craniofacial fixation screws for surgical reconstruction
Solutions tailored for health systems, hospitals, and individual patients

Growth Outlook

Revenue increased to $754,417 in Q2 2026, showing potential for growth
Gross profit margin improved to 77.6% in Q2 2026, indicating operational efficiency
Strong demand for specialized medical devices supports future expansion

Financial Highlights

Trailing twelve months (TTM) revenue of $3,000,000, reflecting steady performance
Net income for Q2 2026 was -$125,947, highlighting ongoing challenges
Current ratio of 0.65 indicates potential liquidity concerns

AI Generated • Aug 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Ross Bjella

Website

www.kelyniam.com

Headquarters

Canton, CT 06019, US

KLYG Financials

Key Financial Metrics (TTM)

Gross Margin

77.32%

Operating Margin

3.35%

Net Income Margin

-6.00%

Return on Equity

-29.31%

Return on Capital

-8.16%

Return on Assets

-12.84%

Earnings Yield

-3.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.52M

Shares Outstanding

50.12M

Volume

1.10K

Avg. Volume

4.43K

Financials (TTM)

Gross Profit

$2.78M

Operating Income

$120.25K

EBITDA

$151.94K

Operating Cash Flow

-$31.33K

Capital Expenditure

$0.00

Free Cash Flow

-$31.33K

Cash & ST Invst.

$96.94K

Total Debt

$384.42K

Kelyniam Global Performance Analysis

Kelyniam Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 3,017,599	13.3%
2023	2023-12-31	USD 2,672,357	-11.4%
2024	2024-12-31	USD 3,328,384	24.5%
2025	2025-12-31	USD 3,053,222	-8.3%

Kelyniam Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	11.2%
Q4	2025-12-31	5.4%
Q1	2026-03-31	32.7%
Q2	2026-06-30	-34.4%

Kelyniam Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.00	N/A
2023	2023-12-31	USD -0.01	114.7%
2024	2024-12-31	USD -0.02	153.4%
2025	2025-12-31	USD -0.00	-84.9%

Kelyniam Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-400.0%
Q4	2025-12-31	181.8%
Q1	2026-03-31	-144.4%
Q2	2026-06-30	-108.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$754.42K

+2.0%

Gross Profit

$577.95K

-6.3%

Gross Margin

76.61%

N/A

Market Cap

$6.52M

N/A

Market Cap/Employee

$724.00K

N/A

Employees

N/A

Net Income

-$125.95K

-321.4%

EBITDA

-$108.69K

-220.7%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$96.94K

-38.6%

Total Debt

$384.42K

-19.7%

Accounts Receivable

$337.30K

-9.1%

Inventory

$77.57K

+85.7%

Long Term Debt

$199.75K

-24.8%

Short Term Debt

$184.67K

-13.2%

Return on Assets

-12.84%

N/A

Return on Invested Capital

13.57%

N/A

Free Cash Flow

-$74.04K

-282.1%

Operating Cash Flow

-$74.04K

-282.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

USAQQHSLab, Inc.

USAQQHSLab, Inc.$0.32-8.57%

IGEXIndo Global Exchange(s) PTE, Ltd.

IGEXIndo Global Exchange(s) PTE, Ltd.$0.00+9.09%

AGNPFGrey Matters Health Inc.

AGNPFGrey Matters Health Inc.$0.37-11.91%

NUMDNu-Med Plus, Inc.

NUMDNu-Med Plus, Inc.$0.02+0.00%

CSOCCaduceus Software Systems Corp.

CSOCCaduceus Software Systems Corp.$0.00+15.38%

MSIUMedical Supply International USA, Inc.

MSIUMedical Supply International USA, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$147.81-0.04%

INTCIntel

INTCIntel$106.06+0.02%

NOKNokia

NOKNokia$10.85+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.90+0.00%

NVDANvidia

NVDANvidia$224.30-0.01%

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF$43.24-0.02%

Questions About KLYG

What is the current price of Kelyniam Global?

Kelyniam Global is trading at $0.13 per share.

What is the 52-week range for Kelyniam Global?

Over the past 52 weeks, Kelyniam Global has traded between $0.07 and $0.30.

How much debt does Kelyniam Global have?

As of the most recent reporting period, Kelyniam Global reported total debt of $384.42K.

How much cash does Kelyniam Global have on hand?

Kelyniam Global reported $96.94K in cash and cash equivalents in its most recent financial results.

What is Kelyniam Global’s dividend yield?

Kelyniam Global does not currently have a dividend yield.

Kelyniam Global(OTC) KLYG

Kelyniam Global Financials at a Glance

KLYG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Kelyniam Global

KLYG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Kelyniam Global Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KLYG

What is the current price of Kelyniam Global?

What is the 52-week range for Kelyniam Global?

How much debt does Kelyniam Global have?

How much cash does Kelyniam Global have on hand?

What is Kelyniam Global’s dividend yield?

Premium Investing Services